KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Change in Cash (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Change in Cash for 16 consecutive years, with -$283.2 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 636.31% to -$283.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.6 million through Dec 2025, up 916.31% year-over-year, with the annual reading at $20.6 million for FY2025, 916.31% up from the prior year.
  • Change in Cash for Q4 2025 was -$283.2 million at Halozyme Therapeutics, down from $357.8 million in the prior quarter.
  • The five-year high for Change in Cash was $357.8 million in Q3 2025, with the low at -$373.0 million in Q4 2021.
  • Average Change in Cash over 5 years is -$589100.0, with a median of $11.2 million recorded in 2022.
  • The sharpest move saw Change in Cash skyrocketed 2390.17% in 2021, then tumbled 15489.59% in 2023.
  • Over 5 years, Change in Cash stood at -$373.0 million in 2021, then soared by 123.34% to $87.0 million in 2022, then crashed by 279.07% to -$155.9 million in 2023, then soared by 75.32% to -$38.5 million in 2024, then plummeted by 636.31% to -$283.2 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$283.2 million, $357.8 million, and -$114.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.